SARAH VENTIMIGLIA: Open Payments
NPI 1548884067 · SAINT CLAIR SHORES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 36 payments from 12 companies in 2025. Trend: 2023 $368 · 2024 $370 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $247 |
| ABBVIE INC. | 4 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Aimmune Therapeutics, Inc. | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| Ardelyx, Inc. | 3 | $56 |
| PFIZER INC. | 2 | $44 |
| GENZYME CORPORATION | 2 | $44 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, DUPIXENT, ZENPEP, IBSRELA, VELSIPITY, XIFAXAN.
Industry payments across MI — which companies pay providers there.
